Búsqueda de un ensayo clínico
Otra(s) opcion(es) de búsqueda
13 Resultado(s)
Ensayo clínico en reclutamiento
= ; Ensayos clínico en curso
=
; Ensayo clínico finalizado
=
; Financiado por un miembro del IRDiRC =
; Estudio en el que participan integrantes de la ERN en al menos dos Estados miembros =
Ensayo(s) clínico(s) nacional(es)

ALEMANIA
Baden-Württemberg
HEIDELBERG

INFORM2 NivEnt: exploratory multinational phase I/II combination study of Nivolumab and Entinostat in children and adolescents with refractory high-risk malignancies-DE
Deutsches Krebsforschungszentrum
Klinische Kooperationseinheit Pädiatrische Onkologie

ALEMANIA
Bayern
REGENSBURG

INFORM2 NivEnt: exploratory multinational phase I/II combination study of Nivolumab and Entinostat in children and adolescents with refractory high-risk malignancies-DE
Universitätsklinikum Regensburg
Abteilung für Pädiatrische Hämatologie, Onkologie und Stammzelltransplantation

ALEMANIA
Niedersachsen
GÖTTINGEN

Autologous Dendritic Cells and Metronomic Cyclophosphamide for Relapsed High-Grade Gliomas in Children and Adolescents
Universitätsmedizin Göttingen
Klinik für Kinder- und Jugendmedizin

ALEMANIA
Nordrhein-Westfalen
ESSEN

INFORM2 NivEnt: exploratory multinational phase I/II combination study of Nivolumab and Entinostat in children and adolescents with refractory high-risk malignancies-DE
Universitätsklinikum Essen
Klinik für Kinderheilkunde III

AUSTRIA
WIEN
ADDRESS: NOT PROVIDED - AT
HIT-HGG-2013: International cooperative Phase III trial of the HIT-HGG study group for the treatment of high grade glioma, diffuse intrinsic pontine glioma, and gliomatosis cerebri in children and adolescents < 18 years - AT
Institution: Information not provided - AT

ITALIA
LAZIO
ROMA
Phase II Open-label Global Study to Evaluate the Effect of Dabrafenib in Combination With Trametinib in Children and Adolescent Patients With BRAF V600 Mutation Positive Low Grade Glioma (LGG) or Relapsed or Refractory High Grade Glioma (HGG) - IT
IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO
U.O. di Oncoematologia

POLONIA
Warszawa
WARSAW

Cooperative Multicenter Study for Children and Adolescents With Low Grade Glioma - PL
Instytut "Pomnik-Centrum Zdrowia Dziecka"
Klinika Onkologii IP-CZD

PAISES BAJOS (LOS)
Noord-Holland
AMSTERDAM
The Drug Rediscovery Protocol (DRUP trial): A Dutch National Study on behalf of the Center for Personalized Cancer Treatment (CPCT) to Facilitate Patient Access to Commercially Available, Targeted Anti-cancer Drugs to determine the Potential Efficacy in Treatment of Advanced Cancers with a Known Molecular Profile (Phase II)
Het Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis
Afdeling Maag-Darm-Leveroncologie

BELGICA
ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
STEP: Sorafenib Long Term Extension Program - BE
Cliniques universitaires Saint-Luc - UCLouvain
Pneumologie_Oncologie thoracique

ESPAÑA
Madrid
ADDRESS: NOT PROVIDED - ES

Estudio de fase 1/2, abierto y de un solo brazo, que evalúa la seguridad y eficacia del ponatinib para el tratamiento de leucemias o tumores sólidos recurrentes o refractarios en pacientes pediátricos -ES
Institution: Information not provided - ES

ESTADOS UNIDOS
Washington
ADDRESS: NOT PROVIDED - US


Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Institution: Information not provided - US

ITALIA
EMILIA ROMAGNA
ADDRESS: NOT PROVIDED - IT

A Randomized, Open-label, Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Patients With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma - IT
Institution: Information not provided - IT

ITALIA
LAZIO
ROMA